Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
1.210
0.00 (0.00%)
Sep 18, 2025, 9:37 AM EDT - Market open
Lexaria Bioscience Market Cap
Lexaria Bioscience has a market cap or net worth of $23.67 million as of September 18, 2025. Its market cap has decreased by -61.70% in one year.
Market Cap
23.67M
Enterprise Value
19.16M
1-Year Change
-61.70%
Ranking
Category
Stock Price
$1.21
Market Cap Chart
Since February 12, 2007, Lexaria Bioscience's market cap has increased from $19.40M to $23.67M, an increase of 21.99%. That is a compound annual growth rate of 1.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 23.70M | -35.42% |
| Dec 31, 2024 | 36.70M | 186.72% |
| Dec 29, 2023 | 12.80M | -12.33% |
| Dec 30, 2022 | 14.60M | -36.80% |
| Dec 31, 2021 | 23.10M | 2.67% |
| Dec 31, 2020 | 22.50M | -24.75% |
| Dec 31, 2019 | 29.90M | -58.30% |
| Dec 31, 2018 | 71.70M | -38.87% |
| Dec 29, 2017 | 117.30M | 624.07% |
| Dec 30, 2016 | 16.20M | 131.43% |
| Dec 31, 2015 | 7.00M | 125.81% |
| Dec 31, 2014 | 3.10M | 342.86% |
| Dec 31, 2013 | 700.00K | -12.50% |
| Dec 31, 2012 | 800.00K | -77.78% |
| Dec 30, 2011 | 3.60M | -7.69% |
| Dec 31, 2010 | 3.90M | 69.57% |
| Dec 31, 2009 | 2.30M | 130.00% |
| Dec 31, 2008 | 1.00M | -94.71% |
| Dec 31, 2007 | 18.90M | -2.58% |
| Feb 12, 2007 | 19.40M | - |
View and export this data all the way back to 2007. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.40B |
| Johnson & Johnson | 426.76B |
| AbbVie | 390.07B |
| UnitedHealth Group | 309.39B |
| Novo Nordisk | 260.64B |
| AstraZeneca | 241.43B |
| Novartis AG | 237.64B |
| Abbott Laboratories | 233.52B |